Showing results (71-80 of 123) with videos related to
Sort By:
Pageof 13
Molecular Cancer Research : MCR|March 18, 2008
CXCL16 functions as a novel chemotactic factor for prostate cancer cells in vitroYi Lu, Jianhua Wang, Yang Xu, et al.Cancer Research|February 12, 2004
Vascular endothelial growth factor contributes to the prostate cancer-induced osteoblast differentiation mediated by bone morphogenetic proteinJinlu Dai, Yasuhide Kitagawa, Jian Zhang, et al.Journal of Cellular Biochemistry|July 27, 2012
The effects of zoledronic acid in the bone and vasculature support of hematopoietic stem cell nichesFabiana N Soki, Xin Li, Janice Berry, et al.Experimental Hematology|November 27, 2010
Annexin-2 is a regulator of stromal cell-derived factor-1/CXCL12 function in the hematopoietic stem cell endosteal nicheYounghun Jung, Yusuke Shiozawa, Jingcheng Wang, et al.Translational Oncology|May 4, 2020
Adrenergic Blockade Promotes Maintenance of Dormancy in Prostate Cancer Through Upregulation of GAS6Ann M Decker, Joseph T Decker, Younghun Jung, et al.Journal of Cellular Biochemistry|May 23, 2003
Expression of CXCR4 and CXCL12 (SDF-1) in human prostate cancers (PCa) in vivoYan-Xi Sun, Jingcheng Wang, Charles E Shelburne, et al.Molecular Cancer Research : MCR|August 21, 2014
Annexin 2-CXCL12 interactions regulate metastatic cell targeting and growth in the bone marrowYounghun Jung, Jingcheng Wang, Eunsohl Lee, et al.Plos One|May 3, 2013
GAS6 receptor status is associated with dormancy and bone metastatic tumor formationRussell S Taichman, Lalit R Patel, Rachel Bedenis, et al.Endocrinology|August 6, 2005
Cells of the osteoclast lineage as mediators of the anabolic actions of parathyroid hormone in boneAmy J Koh, Burak Demiralp, Kathleen G Neiva, et al.Journal of Cellular Biochemistry|May 23, 2013
Erythropoietin supports the survival of prostate cancer, but not growth and bone metastasisYusuke Shiozawa, Samantha McGee, Michael J Pienta, et al.Pageof 13